Loading clinical trials...
Loading clinical trials...
Use of Ivermectin as a Therapeutic Option for Patients With COVID-19
Conditions
Interventions
Ivermectin
Locations
1
Egypt
Waheed Shouman
Zagazig, Sharqia Province, Egypt
Start Date
May 31, 2020
Primary Completion Date
July 30, 2020
Completion Date
August 15, 2020
Last Updated
June 24, 2020
NCT07221162
NCT06721949
NCT06082518
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
Zagazig University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions